Page last updated: 2024-09-04

gadofosveset trisodium and gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate

gadofosveset trisodium has been researched along with gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate in 2 studies

Compound Research Comparison

Studies
(gadofosveset trisodium)
Trials
(gadofosveset trisodium)
Recent Studies (post-2010)
(gadofosveset trisodium)
Studies
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)
Trials
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)
Recent Studies (post-2010) (gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)
2653214563831243

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fisher, E; Reich, DS1
Armspach, JP; de Sèze, J; Dietemann, JL; Jeantroux, J; Kremer, S; Lamy, J; Magnus, A; Oesterle, H; Trunet, S1

Other Studies

2 other study(ies) available for gadofosveset trisodium and gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate

ArticleYear
Imaging new lesions: enhancing our understanding of multiple sclerosis pathogenesis.
    Neurology, 2013, Jul-16, Volume: 81, Issue:3

    Topics: Brain; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Organometallic Compounds

2013
Evaluation of an albumin-binding gadolinium contrast agent in multiple sclerosis.
    Neurology, 2013, Jul-16, Volume: 81, Issue:3

    Topics: Adult; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Organometallic Compounds

2013